PIM3 and pancreatic neoplasm: Consistent with this, we found that miR-33a targeted Pim-3 to increase the chemosensitivity of pancreatic cancer cells and reverse the chemoresistance of pancreatic cancer cells to gemcitabine both in vitro and in vivo.